293 related articles for article (PubMed ID: 11238464)
1. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
[TBL] [Abstract][Full Text] [Related]
2. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
Doucas V; Tini M; Egan DA; Evans RM
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561
[TBL] [Abstract][Full Text] [Related]
3. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
4. Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not.
Wiesmeijer K; Molenaar C; Bekeer IM; Tanke HJ; Dirks RW
J Struct Biol; 2002; 140(1-3):180-8. PubMed ID: 12490166
[TBL] [Abstract][Full Text] [Related]
5. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
6. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus.
Muratani M; Gerlich D; Janicki SM; Gebhard M; Eils R; Spector DL
Nat Cell Biol; 2002 Feb; 4(2):106-10. PubMed ID: 11753375
[TBL] [Abstract][Full Text] [Related]
7. The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome.
Baumann CT; Ma H; Wolford R; Reyes JC; Maruvada P; Lim C; Yen PM; Stallcup MR; Hager GL
Mol Endocrinol; 2001 Apr; 15(4):485-500. PubMed ID: 11266502
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.
Sourvinos G; Tavalai N; Berndt A; Spandidos DA; Stamminger T
J Virol; 2007 Sep; 81(18):10123-36. PubMed ID: 17626080
[TBL] [Abstract][Full Text] [Related]
9. Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies.
Zong RT; Das C; Tucker PW
EMBO J; 2000 Aug; 19(15):4123-33. PubMed ID: 10921892
[TBL] [Abstract][Full Text] [Related]
10. The calcium-responsive transactivator recruits CREB binding protein to nuclear bodies.
Pradhan A; Liu Y
Neurosci Lett; 2004 Nov; 370(2-3):191-5. PubMed ID: 15488321
[TBL] [Abstract][Full Text] [Related]
11. Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator.
Bloch DB; Nakajima A; Gulick T; Chiche JD; Orth D; de La Monte SM; Bloch KD
Mol Cell Biol; 2000 Aug; 20(16):6138-46. PubMed ID: 10913195
[TBL] [Abstract][Full Text] [Related]
12. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins.
Chelbi-Alix MK; de Thé H
Oncogene; 1999 Jan; 18(4):935-41. PubMed ID: 10023669
[TBL] [Abstract][Full Text] [Related]
13. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.
Sternsdorf T; Jensen K; Will H
J Cell Biol; 1997 Dec; 139(7):1621-34. PubMed ID: 9412458
[TBL] [Abstract][Full Text] [Related]
14. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.
Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD
Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818
[TBL] [Abstract][Full Text] [Related]
15. Dual roles for lysine 490 of promyelocytic leukemia protein in the transactivation of glucocorticoid receptor-interacting protein 1.
Liu ST; Lu GY; Hsu YJ; Chang LC; Ho CL; Huang SM
Biochim Biophys Acta; 2013 Aug; 1833(8):1799-810. PubMed ID: 23542129
[TBL] [Abstract][Full Text] [Related]
16. The promyelocytic leukemia nuclear body: sites of activity?
Eskiw CH; Bazett-Jones DP
Biochem Cell Biol; 2002; 80(3):301-10. PubMed ID: 12123283
[TBL] [Abstract][Full Text] [Related]
17. LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies.
Dent AL; Yewdell J; Puvion-Dutilleul F; Koken MH; de The H; Staudt LM
Blood; 1996 Aug; 88(4):1423-6. PubMed ID: 8695863
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
19. The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments.
Xu P; Roizman B
Proc Natl Acad Sci U S A; 2017 May; 114(19):E3823-E3829. PubMed ID: 28439026
[TBL] [Abstract][Full Text] [Related]
20. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
